Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

  • Most investors have written off biotech stocks as a graveyard of broken dreams. While artificial intelligence (AI) captures Wall Street's imagination, the biotech industry -- once the crown jewel of innovation -- has been left for dead.